Corcept Therapeutics Incorporated (CORT) vs Rhythm Pharmaceuticals, Inc. (RYTM)
- Corcept Therapeutics Incorporated CORT 72.63 +1.40%
- Rhythm Pharmaceuticals, Inc. RYTM 112.38 +7.01%
Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc. are of similar size ($7.8B and $7.3B). Rhythm Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.5×. Rhythm Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 61.0% against 30.0%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs −70.6%) and the higher return on invested capital (15.0% vs 0.00%). Across the 17 metrics below, Corcept Therapeutics Incorporated leads on 14 and Rhythm Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | CORT | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.54% | 88.23% | 65.16% |
| Operating margin | 11.51% | (66.70%) | 0.00% |
| Net margin | 16.54% | (70.63%) | 0.00% |
| Free cash flow margin | 20.20% | (29.13%) | 0.00% |
| Return on equity | 21.74% | (167.49%) | (50.12%) |
| Return on assets | 17.16% | (41.75%) | (45.60%) |
| Return on invested capital | 14.97% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack